Aldeyra Therapeutics Expands Retinal Disease Pipeline with Acquisition of Helio Vision
Aldeyra Therapeutics
PR-M01-19-NI-096Feb 01, 2019
Patient Enrollment
Aldeyra Therapeutics Announces First Patient Enrolled in Sjögren-Larsson Syndrome Pivotal Phase 3 Clinical Trial
Aldeyra Therapeutics
PR-M07-18-NI-084Jul 25, 2018
Agreement
CENTOGENE Announces Agreement with Aldeyra Therapeutics for the Advancement of Novel Therapeutics for Patients with Sjögren-Larsson Syndrome
Centogene
PR-M05-18-NI-118May 31, 2018